InventisBio Co

InventisBio Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of InventisBio Co (688382.SS) as of Nov 11, 2026 is -330.07 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -243.52 M CNY — a change of 35.54% (lower).

EBITDA

-330.07 MCNY

YoY

35.54%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of InventisBio Co is 2025 -330.07 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of InventisBio Co was 2024 -243.52 M CNY. It decreases by 35.54% lower compared to the previous year.

The InventisBio Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2020
2.70 M CNY
Jan 1, 2021
-343.05 M CNY
Jan 1, 2022
-499.53 M CNY
Jan 1, 2023
-293.00 M CNY
Jan 1, 2024
-243.52 M CNY
Jan 1, 2025
-330.07 M CNY
The InventisBio Co EBITDA history
YEAREBITDAYoY
-330.07 MCNY+35.54%
-243.52 MCNY-16.89%
-293.00 MCNY-41.34%
-499.53 MCNY+45.61%
-343.05 MCNY-12,796.16%
2.70 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InventisBio Co Stock analysis

What does InventisBio Co do? InventisBio Co Ltd, headquartered in Shanghai, China, operates in the Health Care sector within the Biotechnology industry. The company employs 222 full-time staff and completed its IPO on July 25, 2022. InventisBio focuses on drug research and development for major diseases including tumors and metabolic conditions. Its core products under clinical development include D-0120, D-0502, D-1553, and BPI-D0316, targeting oncology and metabolic disease areas. InventisBio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InventisBio Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of InventisBio Co is -330.07 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of InventisBio Co changed from -243.52 M CNY to -330.07 M CNY, representing a 35.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) InventisBio Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s InventisBio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — InventisBio Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — InventisBio Co